MedTrace Logo

Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer

NCT06973499 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-05-15

No results posted yet for this study

Summary

This is an exploratory, single-center, being conducted at Beijing Haidian Hospital in order to detect the relationship between microbiome of upper gastrointestinal and pathogenesis of multiple primary lung cancer.

Conditions

  • Multiple Primary Lung Cancer
  • Microbial Colonization

Interventions

DIAGNOSTIC_TEST

Microbiome Profiling and Symptom Assessment

GERD symptom assessment: Standardized GERD-Q questionnaire to evaluate reflux symptoms (heartburn, acid regurgitation) and high-risk behaviors. Microbiome analysis: 16S rDNA sequencing of upper gastrointestinal and intratumoral microbiota.

Sponsors & Collaborators

  • Beijing Haidian Hospital

    lead OTHER

Principal Investigators

  • Yuqing Huang, M.D. · Beijing Haidian Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-06
Primary Completion
2024-05-30
Completion
2024-12-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06973499 on ClinicalTrials.gov